Policy
Section
Pol.
Tracking legislation, regulation, and the fight for federal reform.
Section Editor
Ethan Vale — The Strategist
Federal Bills — 2026 Session
Updated Apr 22
View All Bills →
| Bill # | Name | Status | Chamber | Last Action |
|---|---|---|---|---|
|
S.1234
Senate
|
Secure and Fair Enforcement Regulation Banking Act of 2026
Senate Banking Committee advanced bill 12-10 along party lines; floor vote expected Q2 2026
|
In Committee | Federal | Mar 18, 2026 |
|
DEA-2026-01
Executive
|
DEA Final Rule: Cannabis Reclassification from Schedule I to Schedule III
AG Pam Bondi fired April 3; Todd Blanche named interim AG. Early analysis indicates rescheduling trajectory unchanged — Trump has directed DOJ to complete Schedule III rulemaking expeditiously. DEA final rule still expected late 2026.
|
Pending | Federal | Apr 3, 2026 |
|
H.R. 2072
House
|
Veterans Equal Access to Cannabis Therapy Act of 2026
Referred to House Veterans' Affairs Committee; bipartisan co-sponsors added
|
Introduced | Federal | Feb 14, 2026 |
|
S.2089
Senate
|
States Reform Act of 2026
Introduced; referred to Senate Judiciary Committee
|
Introduced | Federal | Jan 28, 2026 |
|
H.R. 4089
House
|
Marijuana Opportunity Commerce and Accountability Act of 2026
House Judiciary subcommittee hearing held; markup scheduled for April
|
In Committee | Federal | Mar 5, 2026 |
|
CMS-BEI-2026
Executive/CMS
|
CMS Substance Access Beneficiary Engagement Incentive — Hemp Products
D.C. federal court denied emergency restraining order; injunction hearing set for April 20, 2026. Program launched April 1 for ACO REACH and EOM model participants.
|
Active_litigation | Federal | Apr 2, 2026 |
|
S.1876
Senate
|
Cannabidiol and Marihuana Research Expansion Act Reauthorization 2026
Passed Senate 92-4; awaiting House floor vote
|
Passed | Federal | Feb 22, 2026 |
|
H.R. 8394
House
|
To streamline the process for institutions of higher education to research marijuana.
Referred to Committees on Energy and Commerce, Judiciary, Agriculture, and Education and Workforce
|
Introduced | Federal | Apr 20, 2026 |
Federal Reform
All Federal →
Policy
Indiana Residents Spend $2 Billion a Year on Cannabis — And the State Spends $20 Million to Stop Them
Jordan Pike
·
May 11
Policy
The Trump Administration’s Drug Strategy Is Out. Marijuana Gets Its Own Chapter.
Ethan Vale
·
May 11
Policy
The Feds Are Closing In on Intoxicating Hemp — and the DEA Just Made the Legal Case
Ethan Vale
·
May 8
State Legislation
All States →
Policy
Trump’s Rescheduling Order Is Real — and It’s Already Creating More Confusion Than Clarity
Ethan Vale
·
May 5
Policy
The Senate Is Asking the VA to Build a Psychedelics Office Before the FDA Even Approves Anything
Ethan Vale
·
Apr 30
Policy
Treasury and IRS Promise 280E Relief Is Coming — Here’s What Cannabis Operators Actually Need to Know
Ethan Vale
·
Apr 30
Regulation & Compliance
All Regulation →
Policy
Congress Introduces Bill to Open Federal Cannabis Research. Here’s What’s Still Blocking University Labs.
Ethan Vale
·
Apr 22
Policy
Senate Advanced Cannabis Banking Reform on a Party-Line Vote. That Should Worry Operators.
Ethan Vale
·
Apr 17
Policy
DEA Cannabis Rescheduling Decision: What to Expect in 2026
Ethan Vale
·
Apr 15
International Policy
Global Coverage →
Policy
The Senate Voted 92-4 to Fix Cannabis Research. The House Hasn’t Moved in 51 Days.
Ethan Vale
·
Apr 14
Policy
Alcohol Distributors Want to Save Hemp THC Drinks. They Also Want to Control Them.
Ethan Vale
·
Apr 10
Policy
A Major New Review Found No RCT Evidence Cannabis Works for PTSD. Thirty-Eight States Still List It as a Qualifying Condition.
Ethan Vale
·
Apr 1
◆ Data Feature · Rescheduling Watch
Federal Rescheduling Is No Longer a Question of If — It’s a Question of What Comes Next
The DEA’s administrative law hearing marks the first time federal cannabis policy will be argued in open court with formal evidentiary standards. A Schedule III ruling won’t end the fight — it will redefine it. Banking restrictions, 280E taxation, and interstate commerce remain locked until Congress acts. Here’s the full policy landscape heading into the hearing.
Sched. III
Proposed Status
47 days
To DEA Hearing
24 states
Rec. Legal
68 %
Congressional Support
Schedule Status
I → III
Proposed reclassification pending hearing
DEA Hearing Timeline
May 2026
Administrative Law Court, Washington D.C.
States Legalized
24 rec.
38 medical · as of March 2026
Congressional Support
68%
Bipartisan majority across House & Senate
Analysis & Voices
Analysis
Indiana Residents Spend $2 Billion a Year on Cannabis — And the State Spends $20 Million to Stop Them
A new economic analysis finds Hoosiers are already spending nearly $2 billion annually on cannabis — mostly in neighboring states or on the illicit market — while Indiana spends up to $20 million a year enforcing a prohibition that isn't working.
Read the full analysis →
May 11, 2026
Analysis
The Trump Administration’s Drug Strategy Is Out. Marijuana Gets Its Own Chapter.
The Office of National Drug Control Policy has released the first National Drug Control Strategy of the Trump era, and cannabis occupies an unusually prominent position in a document traditionally focused on opioids and hard drugs. The strategy signals a federal government newly unified in its suspicion of marijuana — and sets the table for enforcement action that could reshape the legal industry.
Read the full analysis →
May 11, 2026